Clinical trials recruiting in Kazakhstan

Phase breakdown

Cities in Kazakhstan

Conditions recruiting in Kazakhstan

Recruiting trials in Kazakhstan

• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
  NCT06226883 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female)
• Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
  NCT07512934 · Phase: Not specified · Ages: 18 Years to 74 Years · Sex: All (male and female)
• CorWave LVAS FIH Study
  NCT06907017 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
  NCT07728669 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 65 Years · Sex: All (male and female)
• Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
  NCT06410352 · Phase: Phase 4 · Ages: 35 Years to 65 Years · Sex: All (male and female)
• Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
  NCT06953180 · Phase: Not specified · Ages: 18 Years to 69 Years · Sex: All (male and female)
• Expanding Medication-Assisted Therapies in Central Asia
  NCT05579470 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
  NCT06314282 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
  NCT06632457 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
  NCT06632444 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Prospective Urban Rural Epidemiology Study
  NCT03225586 · Phase: Not specified · Ages: 35 Years to 70 Years · Sex: All (male and female)
• Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
  NCT06705023 · Phase: Phase 2 · Ages: 21 Years to 80 Years · Sex: All (male and female)
• TSBL-Based Versus BMI-Based Biliopancreatic Limb Length in One-Anastomosis Gastric Bypass
  NCT07796503 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• The Gut Microbiome in Chronic Heart Failure
  NCT06573892 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
  NCT07495020 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
  NCT03549754 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Kazakhstan?

16 recruiting trials have at least one study site in Kazakhstan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.